Navigation Links
HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
Date:9/26/2007

regulatory proceedings that may be brought against us or any adverse outcome relating to the settlement of the federal securities class action previously disclosed by us; significant changes in HealthSouth's management team; HealthSouth's ability to successfully consummate transactions related to its previously announced strategic repositioning; HealthSouth's ability to continue to operate in the ordinary course and manage its relationships with its creditors, including its lenders, bondholders, vendors and suppliers, employees, and customers; HealthSouth's ability to successfully remediate its internal control weakness; changes, delays in, or suspension of reimbursement for HealthSouth's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and HealthSouth's response thereto; HealthSouth's ability to obtain and retain favorable arrangements with third- party payors; HealthSouth's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages; general conditions in the economy and capital markets; and other factors which may be identified from time to time in the company's SEC filings and other public announcements, including HealthSouth's Form 10-K for the year ended December 31, 2006 and related Current Report on Form 8-K filed on March 30, 2007.

Media Contact:

Andy Brimmer, 205-410-2777


'/>"/>
SOURCE HealthSouth Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. WHO Declares Vietnam First Country to Control SARS
2. Prime Minister Declares War on AIDS
3. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
4. Iranian Government Declares Holiday Due To Pollution
5. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
6. Fao Declares Humans Spread Avian Influenza Virus
7. Myanmar Declares Herself As A Country Free of Bird flu
8. Ramadoss Declares India Yaws Free
9. China Declares War on Unsafe Foods for Soldiers
10. Harmison Ruled Out Off Test Series Due to Hernia
11. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...ON, July 24 /PRNewswire-FirstCall/ --, Key Highli... of expectations and is now,raising targets for th...oup,revenues(1) of GBP492m up 6%, bringing Group o...ar. Misys is executing on its strategy and enterin...ding a platform for growth., To view the Multimed...
(Date:7/23/2008)...N-SALEM, N.C. A study out of Wake Forest Universi...oom doctors are correctly identifying patients who...ests haven,t yet confirmed it. , The study used ...patients with heart attack symptoms who were admit...ipating U.S. centers. , The findings were relea...
(Date:7/23/2008)...ne of vaccines for Immigration and Naturalization ...Health, BALTIMORE, July 23 /PRNewswire/ -- New va...ing for an immigrant visa for entry into the U.S. ...ent residence. Applicants,must show proof of vacci...ecommended by the U.S. Advisory Committee on Immun...
(Date:7/23/2008)...ng varicose veins in scrotum boosts sperm count, m...24 (HealthDay News) -- A simple, minimally invasiv...tility and improve a couple,s chances of having a ...d varicocele, is a network of tangled blood vessel...tion of blood through the veins in the testicles. ...
Breaking Medicine News(10 mins):Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3
...University of California Board of Regents today ap...million toward the development of the first phase...lanning to build a 289-bed, integrated medical cen...cer patients on a 14.5-acre parcel, which is south...
...heme educating coaches and referees in the dangers...duction in the number of spinal injuries suffered ...is weeks BMJ. Spinal cord injuries, although rar... permanently disabling injuries and death in rugby...
...ntists from Australia and UK writing in the Lancet...p cut down the risks of mothers-to-be developing ...s of 31 trials involving more than 32,000 women fo...protective effect of this drug against pre-eclamps...
...ntists at the University of Virginia and the Medic...e that participates in the regulation of the body...n regulating metabolism. Their finding shows that...ich is regulated by the circadian clock in the org...
Other Medicine News:Health News:UC Regents Approve Fundraised Campaign for UCSF Medical Center at Mission Bay 2Health News:Innovative Education Scheme Sees Fewer Rugby Players Suffering Spinal Injuries 2Health News:Research Favors Aspirin In Prevention Of Pre-Eclampsia 2Health News:Clock Gene Plays Role in Weight Gain, Study Finds 2
(Date:7/22/2008)...y Demonstrates Feasibility and Efficacy of Treatin...iver Cancer, SAN FRANCISCO, and YONGIN-SI, South ... Francisco, CA and Ottawa, Ontario), and its South... that novel findings from,a Phase I clinical trial...rated that the product was well-tolerated and resu...
(Date:7/22/2008)...TH SAN FRANCISCO, Calif., July 22 /- ...t has completed patient enrollment,in its Phase 1/...ity and,ammonia scavenging effects of HPN-100 (for...ylbutyrate) in patients with urea cycle disorders,...lts in the fourth quarter,of this year., (Logo: ...
(Date:7/22/2008)...HIA ANTIPOLIS, France, July 22 /PRNewswire-FirstCa...unced it has successfully completed the,enrollment...ed hypertension,in two clinical pharmacology studi...nnounced timelines. These trials are designed to a...n comparison to ibuprofen and,naproxen, using the ...
(Date:7/21/2008)... YORK, July 21 /- Ari Kiev, M.D., pre... speaker at the upcoming conference Wall,Street Un...ement,s Guide to,Wall Street. The conference will ...errace, 267 Fifth Avenue in New York. The event is...d mid-cap life science companies to gain,better in...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Coherent Inc to Webcast First Fiscal Quarter 2008 Results 9937 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 2Vapotherm 28R 29 Announces Validation of U S Patent 2694 1Vapotherm 28R 29 Announces Validation of U S Patent 2694 2Clinimetrics Celebrates 20th Anniversary in Contract Research Business 2690 1
...FirstCall/ -- Vical,Incorporated today announced t...d positive results following interim analysis of d... 3 trial of an,angiogenesis product candidate usin...ndings that the primary efficacy,endpoint in the t...ce and that there were no major safety concerns re...
...AMADEO, one of the,first studies to compare the p...ockers in hypertensive patients with,diabetic nep...f Hypertension, Milan. The results from this study...ignificantly greater extent,than losartan.(1) ...ss, Foothills Hospital,in Calgary, Canada said "T...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
...NE polypropylene mesh is constructed of knitted fi...position to that used in PROLENE* Polypropylene Su...CON, INC.). The mesh is approximately,0.020 inches...been reported to be non-reactive and to retain its...
Surgisis Inguinal Hernia Matrix is implanted to reinforce soft tissues in the inguinal floor to repair inguinal hernias. Supplied sterile in peel-open packages. Intended for one-time use.
...enus-i Laser System is a new, portable, light weig...ations in dermatology, cosmetic and plastic surger...l laser for skin resurfacing, it is the smallest, ...the market. It provides an ideal treatment for you...
...digo OPTIMA Laser System is designed to induce int...ng a near infrared laser source. When used to indu...ers a controlled level of laser energy to heat the...ue necrosis rapidly occurs, but below temperatures...
Medicine Products: